But the tirzepatide shortage was declared resolved in December 2024, and the semaglutide shortage was declared resolved in February 2025
Mounjaro ~22.5% average body weight loss Significant weight reduction Improves blood sugar levels Clinically proven weight loss Key Takeaways: Understanding Digestive Changes on Mounjaro Digestive symptoms can occur during treatment with the weight loss injection Mounjaro
Clinical trials used 2.4 mg as the primary endpoint dose, where participants lost an average of 14.9% of body weight over 68 weeks
If you want the fuller treatment of receptor competition, the absence of combination trial data, and sequential-versus-concurrent study design, read our companion guide on whether researchers can take retatrutide and semaglutide together
The prevalence is similar globally, he explained, although exact figures can vary based on regional health demographics and reporting practices. Most commonly, it affects middle-aged or older white people
However, individual circumstances vary, so discuss combinations with your prescriber